Kodiak Sciences Statistics
NASDAQ: KODHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
91.08-1.26 (-1.36%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Kodiak Sciences by the numbers
Kodiak Sciences has a market capitalization of $5.72 billion based on 62.85M shares outstanding. With trailing EPS of $-4.19, Kodiak Sciences is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 99.3% above its 50-day average and 150.9% above its 200-day average.
Average daily trading volume is 1.57M shares, or about $142.8 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
KOD valuation vs. peer median
| Metric | KOD | Peer median | Difference |
|---|---|---|---|
| Market cap | $5.72B | $5.10B | +12% |
| Avg. volume | 1.57M | 1.54M | +2% |
Peer median across 8 companies: IOVA, CGON, SRRK, CRSP, IMVT, ADPT, RLAY, TARS.
Valuation
- Market cap
- $5.72B
- EPS (TTM)
- $-4.19
- Shares outstanding
- 62.85M
Price and trading
- Previous close
- 92.34
- Open
- 91.74
- Day range
- 89.91 – 94.24
- 52-week range
- 10.94 – 104.00
- 52-week change
- +540.06%
- Beta
- —
- Volume
- 1.30M
- Average volume
- 1.57M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 12, 2026
Additional statistics
- Market Cap
- 5.72B
- Forward Pe
- -26.51
- Eps
- -4.19
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 104.00
- Week52 Low
- 10.94
- Avg Volume
- 1.57M
- Shares Outstanding
- 62.85M
- Ma50
- 45.71
- Ma200
- 36.31
- Earnings Date
- Nov 12, 2026
- Pct From52w High
- -12.42%
- Pct From52w Low
- 732.54%